425,410 research outputs found
Reversibility of cell surface label rearrangement
Cell surface labeling can cause rearrangements of randomly distributed membrane components. Removal of the label bound to the cell surface allows the membrane components to return to their original random distribution, demonstrating that label is necessary to maintain as well as to induce rearrangements. With scanning electron microscopy, the rearrangement of concanavalin A (con A) and ricin binding sites on LA-9 cells has been followed by means of hemocyanin, a visual label. The removal of con A from its binding sites at the cell surface with alpha- methyl mannoside, and the return of these sites to their original distribution are also followed in this manner.
There are labeling differences with con A and ricin. Under some conditions, however, the same rearrangements are seen with both lectins. The disappearance of labeled sites from areas of ruffling activity is a major feature of the rearrangements seen. Both this ruffling activity and the rearrangement of label are sensitive to cytochalasin B, and ruffling activity, perhaps along with other cytochalasin-sensitive structure, may play a role in the rearrangements of labeled sites
Cannabinoid receptor interacting protein suppresses agonist-driven CB1 receptor internalization and regulates receptor replenishment in an agonist-biased manner
Cannabinoid receptor interacting protein 1a (CRIP1a) is a CB1 receptor (CB1R) distal C-terminus-associated protein that modulates CB1R signaling via G proteins, and CB1R down-regulation but not desensitization (Blume et al. [2015] Cell Signal., 27, 716-726; Smith et al. [2015] Mol. Pharmacol., 87, 747-765). In this study, we determined the involvement of CRIP1a in CB1R plasma membrane trafficking. To follow the effects of agonists and antagonists on cell surface CB(1)Rs, we utilized the genetically homogeneous cloned neuronal cell line N18TG2, which endogenously expresses both CB1R and CRIP1a, and exhibits a well-characterized endocannabinoid signaling system. We developed stable CRIP1a-over-expressing and CRIP1a-siRNA-silenced knockdown clones to investigate gene dose effects of CRIP1a on CB1R plasma membrane expression. Results indicate that CP55940 or WIN55212-2 (10 nM, 5 min) reduced cell surface CB1R by a dynamin-and clathrin-dependent process, and this was attenuated by CRIP1a over-expression. CP55940-mediated cell surface CB1R loss was followed by a cycloheximide-sensitive recovery of surface receptors (30120 min), suggesting the requirement for new protein synthesis. In contrast, WIN55212-2-mediated cell surface CB(1)Rs recovered only in CRIP1a knockdown cells. Changes in CRIP1a expression levels did not affect a transient rimonabant (10 nM)mediated increase in cell surface CB(1)Rs, which is postulated to be as a result of rimonabant effects on \u27non-agonist-driven\u27 internalization. These studies demonstrate a novel role for CRIP1a in agonist-driven CB1R cell surface regulation postulated to occur by two mechanisms: 1) attenuating internalization that is agonist-mediated, but not that in the absence of exogenous agonists, and 2) biased agonist-dependent trafficking of de novo synthesized receptor to the cell surface
Recommended from our members
Glucocorticoid-regulated localization of cell surface glycoproteins in rat hepatoma cells is mediated within the Golgi complex.
Glucocorticoid hormones regulate the post-translational maturation and sorting of cell surface and extracellular mouse mammary tumor virus (MMTV) glycoproteins in M1.54 cells, a stably infected rat hepatoma cell line. Exposure to monensin significantly reduced the proteolytic maturation and externalization of viral glycoproteins resulting in a stable cellular accumulation of a single 70,000-Mr glycosylated polyprotein (designated gp70). Cell surface- and intracellular-specific immunoprecipitations of monensin-treated cells revealed that gp70 can be localized to the cell surface only in the presence of 1 microM dexamethasone, while in uninduced cells gp70 is irreversibly sequestered in an intracellular compartment. Analysis of oligosaccharide processing kinetics demonstrated that gp70 acquired resistance to endoglycosidase H with a half-time of 65 min in the presence or absence of hormone. In contrast, gp70 was inefficiently galactosylated after a 60-min lag in uninduced cells while rapidly acquiring this carbohydrate modification in the presence of dexamethasone. Furthermore, in the absence or presence of monensin, MMTV glycoproteins failed to be galactosylated in hormone-induced CR4 cells, a complement-selected sorting variant defective in the glucocorticoid-regulated compartmentalization of viral glycoproteins to the cell surface. Since dexamethasone had no apparent global effects on organelle morphology or production of total cell surface-galactosylated species, we conclude that glucocorticoids induce the localization of cell surface MMTV glycoproteins by regulating a highly selective step within the Golgi apparatus after the acquisition of endoglycosidase H-resistant oligosaccharide side chains but before or at the site of galactose attachment
Profound Re-Organization of Cell Surface Proteome in Equine Retinal Pigment Epithelial Cells in Response to In Vitro Culturing
The purpose of this study was to characterize the cell surface proteome of native compared to cultured equine retinal pigment epithelium (RPE) cells. The RPE plays an essential role in visual function and represents the outer blood-retinal barrier. We are investigating immunopathomechanisms of equine recurrent uveitis, an autoimmune inflammatory disease in horses leading to breakdown of the outer blood-retinal barrier and influx of autoreactive T-cells into affected horses' vitrei. Cell surface proteins of native and cultured RPE cells from eye-healthy horses were captured by biotinylation, analyzed by high resolution mass spectrometry coupled to liquid chromatography (LC MS/MS), and the most interesting candidates were validated by PCR, immunoblotting and immunocytochemistry. A total of 112 proteins were identified, of which 84% were cell surface membrane proteins. Twenty-three of these proteins were concurrently expressed by both cell states, 28 proteins exclusively by native RPE cells. Among the latter were two RPE markers with highly specialized RPE functions: cellular retinaldehyde-binding protein (CRALBP) and retinal pigment epithelium-specific protein 65kDa (RPE65). Furthermore, 61 proteins were only expressed by cultured RPE cells and absent in native cells. As we believe that initiating events, leading to the breakdown of the outer blood-retinal barrier, take place at the cell surface of RPE cells as a particularly exposed barrier structure, this differential characterization of cell surface proteomes of native and cultured equine RPE cells is a prerequisite for future studies
The Murine Cell Surface Antigen Pc-1 as a Marker for Plasma Cell
The murine plasma cell antigen PC-1 is a cell surface glycoprotein which is disulfic-bond homodimer of Mr 115 kD. It is expressed in large amounts of neoplastic plasma cell and on the majority of haemolytic plaque-forming cells1. It is also found in non-lymphoid tissues.1'2 In this paper a report of detailed distribution of PC-1 in a variety of normal lymphoid tissues using radioiodinated JR-518 monoclonal anti-PC-1 antibody as a probe is given, followed by autoradiography. Because the number of plasma cells in normal condition is very small, mice infected withMesocestoides corti have been used. These M.corti infected mice have high levels of IgGI in their serum (Mitchell et al, 1977). Hence, it was expected that the number of plasma cells may also be increased. Most small lymphocytes are negative of weakly positive. Cells that had morphology of typical plasma cells were mosdy positive. The large immunoglobulm-containing cells found in peritoneum of M.corti infected mice were strongly positive for PC-1. These results show that PC-1 antigen is expressed on normal plasma cells, the normal counterpart of myeloma cells. Therefore it can be used as a plasma surface marker
Structure of a bacterial cell surface decaheme electron conduit
Some bacterial species are able to utilize extracellular mineral forms of iron and manganese as respiratory electron acceptors. In Shewanella oneidensis this involves decaheme cytochromes that are located on the bacterial cell surface at the termini of trans-outer-membrane electron transfer conduits. The cell surface cytochromes can potentially play multiple roles in mediating electron transfer directly to insoluble electron sinks, catalyzing electron exchange with flavin electron shuttles or participating in extracellular intercytochrome electron exchange along “nanowire” appendages. We present a 3.2-Å crystal structure of one of these decaheme cytochromes, MtrF, that allows the spatial organization of the 10 hemes to be visualized for the first time. The hemes are organized across four domains in a unique crossed conformation, in which a staggered 65-Å octaheme chain transects the length of the protein and is bisected by a planar 45-Å tetraheme chain that connects two extended Greek key split ß-barrel domains. The structure provides molecular insight into how reduction of insoluble substrate (e.g., minerals), soluble substrates (e.g., flavins), and cytochrome redox partners might be possible in tandem at different termini of a trifurcated electron transport chain on the cell surface
Impaired Intracellular Transport and Cell Surface Expression of Nonpolymorphic HLA-E
The assembly of the classical, polymorphic major histocompatibility complex class I molecules
in the endoplasmic reticulum requires the presence of peptide ligands and ~2-microglobulin
(~2m). Formation of this trimolecular complex is a prerequisite for e~cient transport to the
cell surface, where presented peptides are scanned by T lymphocytes. The function of the other
class I molecules is in dispute. The human, nonclassical class I gene, HLA-E, was found to be
ubiquitously transcribed, whereas cell surface expression was dif~cult to detect upon transfection.
Pulse chase experiments revealed that the HLA-E heavy chain in transfectants, obtained with
the murine myeloma cell line P3X63-Ag8.653 (X63), displays a significant reduction in
oligosaccharide maturation and intracellular transport compared with HLA-B27 in corresponding
transfectants. The accordingly low HLA-E cell surface expression could be significantly enhanced
by either reducing the culture temperature or by supplementing the medium with human ~2m,
suggesting inefficient binding of endogenous peptides to HLA-E. To analyze whether HLA-E
binds peptides and to identify the corresponding ligands, fractions of acid-extracted material from
HLA-E/X63 transfectants were separated by reverse phase HPLC and were tested for their ability
to enhance HLA-E cell surface expression. Two fractions specifically increased the HLA class
I expression on the HLA-E transfectant clone
The HLA-E Gene encodes two differentially regulated Transcripts and a Cell Surface Protein
An HLA-E-specific oligonucleotide probe was used
to study the expressioonf HLA-E. This probed etects
two HLA-E transcripts, 1.8 and 2.7 kb in size, which
are present in varying ratios in allt issues and cell
lines investigated. We demonstrate that alternative
poly(A) site usage accounts for the differential regulation
of the two HLA-E mRNA species. Sequence
analysis of three cDNA clones, representing the two
transcripts of HLA-E, and of anH LA-E gene encoded
by cosmid cd3.14, revealed identity of gene and
cDNA in the 3’ untranslated region. S1 nuclease
protection assays confirmed that the two HLA-E
transcripts are not alternative splicing products.
Introduction of cd3.14, together with human ,&m
into the murine myeloma cell line P3X63-Ag8.653,
resulted in a cell surface expresosf ioan HLA-class
I heavy chain detectablbey indirect immunofluorescence
whereas transfection into the humBaznr n expressing
mouse L cell line, 527 was negative with
regard to cell surface expressionC. ell surface labeling
of transfectants and immunoprecipitation with
a monomorphic HLA class I-specific antibodyo r an
antibody against human &m confirmed the presence
of an HLA-E H chain on the cell surface. These
results indicate that the HLA-E gene codes for a
class I H chain that can be expressed on the cell
surface
Tuning cell surface charge in E. coli with conjugated oligoelectrolytes.
Cationic conjugated oligoelectrolytes (COEs) varying in length and structural features are compared with respect to their association with E. coli and their effect on cell surface charge as determined by zeta potential measurements. Regardless of structural features, at high staining concentrations COEs with longer molecular dimensions associate less, but neutralize the negative surface charge of E. coli to a greater degree than shorter COEs
The NAE Pathway : autobahn to the nucleus for cell surface receptors
Various growth factors and full-length cell surface receptors such as EGFR are translocated from the cell surface to the nucleoplasm, baffling cell biologists to the mechanisms and functions of this process. Elevated levels of nuclear EGFR correlate with poor prognosis in various cancers. In recent years, nuclear EGFR has been implicated in regulating gene transcription, cell proliferation and DNA damage repair. Different models have been proposed to explain how the receptors are transported into the nucleus. However, a clear consensus has yet to be reached. Recently, we described the nuclear envelope associated endosomes (NAE) pathway, which delivers EGFR from the cell surface to the nucleus. This pathway involves transport, docking and fusion of NAEs with the outer membrane of the nuclear envelope. EGFR is then presumed to be transported through the nuclear pore complex, extracted from membranes and solubilised. The SUN1/2 nuclear envelope proteins, Importin-beta, nuclear pore complex proteins and the Sec61 translocon have been implicated in the process. While this framework can explain the cell surface to nucleus traffic of EGFR and other cell surface receptors, it raises several questions that we consider in this review, together with implications for health and disease
- …
